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AIM 
To study the  polymorphic variants in CYP2C9*2*3 and the C-174G promoter polymorphism of the IL-6 gene on Infertile Women.  
BACKGROUND 
•Infertility affects 15–20% of couples worldwide. Within the past decades, there has been a steady rise in the treatment of female infertility 
with several drugs (Udell et al, CMAJ, 2017). 
•The cytochrome P450 (CYP) genes are oxygenases involved in estrogen biosynthesis and metabolism, generation of DNA damaging procarcinogens, 
and response to anti-estrogen therapies (Blackburn et al, Cancer Causes and Control, 2015) 
•IL6 Interleukin-6 (IL-6) is a pleiotropic cytokine expressed in many tissues. This cytokine is largely expressed in female urogenital tract as well 
as reproduction organs. Very high or very low levels of IL-6 are associated with estrogen metabolism imbalance (Prins et al, J Reprod Immunol, 
2012). 
METHODOLOGICAL STRATEGY 
RESULTS 
1. Some samples did not amplified. To the CYP2C9*2 allele we got amplification in 8 samples. 
All of them were WildType genotype (80%) Vs 77.6% in a control population. To the CYP2C9*3 
we got amplification in 5 samples. 60% were wildtype genotype (AA), 20% were heterozigotic 
(AC) and 20% were homozygous for the mutation (CC). The frequency of AC and CC genotypes 
in a control population are 12.1% and 0.45% respectively (Vasilyev, et al, Res Pharm Sci, 2016). 
CONCLUSIONS 
2. DNA was extracted from urine sediments 
3. LightMix Kit for the detection of CYP 2C9 alleles *2,and *3 and LightMix Kit for the detection of 
IL6 G-174C were used with LightCycler 2.0 Instrument. 
1. 10 infertile patients were targeted in this study.  
• CYP2C9*3 C mutant and IL6-174C/G heterozygote genotypes may represent potential biomarkers for female infertility.   
• On the other hand, they may have prognostic significance, namely regarding the metabolism of drugs used in infertility treatments, something which will need to be addressed in further 
studies.  
•Their role in female infertility should be clarified using a larger group of infertile women. 
 
R. Cardoso 1, A. Gonçalves2, JM da Silva2, C. Oliveira2, P. Xavier2, H. Alves 1,3, A. Barros2,4, MC Botelho1,5 
1 - INSA, National Institute of Health Dr. Ricardo Jorge, Porto, Portugal. 2 - Centre for Reproductive Genetics Prof. Alberto Barros, Porto, Portugal. 3 – Fundação Professor Ernesto Morais. 4 - Department of Genetics, 
Faculty of Medicine, University of Porto, Porto, Portugal. 5 – i3S, Instituto de Investigação e Inovação em Saúde. 
Fig. 4: Heterozigotic patient sample melting peak for CYP2C9*3 
2. Some samples did not amplified. IL6 – CC genotype was not found, IL6 -
174C/G genotype that is known to be associated with lower IL6 secretion 
was 80%. The frequency of GC genotype in a  Caucasian control population 
is 44% (Fishman et al, J Clin Invest, 1998). 
 
Fig. 5: Heterozigotic patient sample melting peak for IL6 -174G/C 
Fig. 1: Estrogen metabolism imbalance  
in infertility 
Fig.2: Control samples melting peak for CYP2C9*3 (left panel heterozygote; right panel mutant)   Fig. 3: Control sample melting peak for IL6 G-174C 
